Patent ID: 8486992

Claim:
A kit comprising a) a pharmaceutical composition comprising a combination of a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: R 1 is CN or CONH 2 ; A is selected from wherein * and ** represent the attachment points, ** being linked to the oxygen, R 2 and R 3 are methyl or where A is a group of formula R 2 and R 3 may also together form with the carbon atom to which they are linked a cyclopentane ring; p is 0 or 1; A l is selected from a) phenyl optionally substituted with 1, 2 or 3 groups independently selected from halo, CN, CF 3 , OR 4 , SR 4 , OCF 3 , (C 1 -C 4 )alkyl and phenyl optionally substituted with OH; b) naphthyl optionally substituted with 1 or 2 groups selected from halo, CN, CF 3 , OR 4 , SR 4 , OCF 3 and (C 1 -C 4 )alkyl; c) a 9 or 10-membered bicyclic aromatic heterocyclic group, containing from 1, 2 or 3 heteroatoms independently selected from O, S or N, said heterocyclic group being optionally substituted with 1 or 2 substituents independently selected from OR 4 , (C 1 -C 4 )alkyl and halo; and R 4 is H or (C 1 -C 4 )alkyl; and a pharmaceutically acceptable carrier or diluent; and b) a pharmaceutical composition comprising a long acting β 2 agonist selected from the group consisting of: salbutamol, terbutaline, bambuterol, fenoterol, salmeterol, formoterol, tulobuterol or a salt thereof and a pharmaceutically acceptable carrier or diluent.